Sumitovant Biopharma To Buy Remaining Stake In Myovant In $1.7 Bln Cash Deal
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
(RTTNews) – Sumitovant Biopharma Ltd., owned by Sumitomo Pharma Co., Ltd., announced late Sunday a definitive agreement to acquire the remaining stake in Myovant Sciences (MYOV) not already owned by Sumitovant for $27.00 per share in cash.
:max_bytes(150000):strip_icc():format(jpeg)/Primary-Image-how-to-trade-0dte-options-7481013-c9af6887219942dc9c8c9374963b51ec.jpg "How to Trade 0DTE Options")
